Home › Funds › Deep Track Capital, LP › IMVT

Deep Track Capital, LP position in IMVT

IMMUNOVANT INC COM · Health Care

Deep Track Capital, LP reported holding 9,341,151 shares of IMVT (IMMUNOVANT INC COM) in its Q2 2026 13F filing — a position valued at US$359.9M, representing 5.36% of its reported portfolio and ranking #2 among its reported holdings. Deep Track Capital, LP has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)9.34M sh
Reported value held$359.91M
Portfolio Weight5.36%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's IMVT position evolved

Deep Track Capital, LP first disclosed a stake in IMVT in Q3 2023 at 2,797,955 shares (US$107.4M). The position peaked in Q2 2026 at 9,341,151 shares, worth US$359.9M. Across 12 filings, Deep Track Capital, LP increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 9,341,151 shares valued at US$359.9M — a reduction of -2,185,820 shares quarter over quarter.. Notable position changes include a 64% trim in Q4 2023 (shares fell 23% over the following quarter), a 485% increase in Q2 2024 (shares rose 8% over the following quarter), a 58% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.80M $107.41M New
Q4 2023 1.00M $42.13M Reduce
Q1 2024 493.35K $15.94M Reduce
Q2 2024 2.88M $76.13M Add
Q3 2024 4.35M $123.95M Add
Q4 2024 6.00M $148.62M Add
Q1 2025 9.50M $162.35M Add
Q2 2025 9.50M $152.00M Hold
Q3 2025 9.73M $156.83M Add
Q4 2025 11.53M $293.02M Add
Q1 2026 11.53M $286.33M Hold
Q2 2026 9.34M $359.91M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC COM) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M), BAKER BROS. ADVISORS LP (US$209.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has Deep Track Capital, LP held IMVT?

Deep Track Capital, LP has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Deep Track Capital, LP's current position in IMVT?

As of Q2 2026, Deep Track Capital, LP holds 9.34M shares of IMVT (IMMUNOVANT INC COM), valued at $359.91M, representing 5.36% of its reported portfolio and ranking #2.

Has Deep Track Capital, LP been buying or selling IMVT?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP reduced its position in IMVT. The position peaked in Q2 2026 at 9.34M shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.